European Association for the Study of Diabetes

The latest news from the EASD Annual Meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News

CAROLINA: Linagliptin, glimepiride show similar CV safety in lower-risk type 2 diabetes

October 1, 2019
Adults with early type 2 diabetes and elevated cardiovascular risk who were assigned the DPP-IV inhibitor linagliptin were no more likely to…
Meeting News

New drug trial results from EASD

September 29, 2019
Endocrine Today has compiled a list of breaking drug trial news reports posted from the annual meeting of the European Association for the Study of…
Meeting News

Cardiovascular risks amplified by HbA1c variability in type 2 diabetes

September 25, 2019
Adults with type 2 diabetes may be at greater risk for major adverse cardiovascular events and microvascular complications if they frequently…
Meeting News

Lower birth weight may result in 'more severe' type 2 diabetes

September 24, 2019
Among a cohort of Scottish adults with type 2 diabetes, those who were born with a weight below 2.893 kg developed diabetes earlier and at a lower…
Meeting News

Bariatric surgery holds potential CV benefits, hyperglycemia risks for adults with type 1 diabetes

September 24, 2019
Adults with obesity and type 1 diabetes may be at lower risk for cardiovascular death, heart failure, stroke and cardiovascular disease after…
Meeting News

IVF tied to increased gestational diabetes risk

September 23, 2019
Pregnant women who use in vitro fertilization to conceive are 53% more likely to develop gestational diabetes when compared with women who conceive…
Meeting NewsPerspective

DAPA-HF: SGLT2 inhibitor reduces heart failure risk even for patients without diabetes

September 23, 2019
The diabetes medication dapagliflozin was shown to reduce the risk for worsening heart failure and cardiovascular death among adults with heart…
Meeting News

Vitamin D deficiency tied to risk for diabetes death

September 22, 2019
Adults with vitamin D deficiency are more likely to die of complications from diabetes during 10 years of follow-up when compared with vitamin…
Meeting News

CONCLUDE: ‘Uncertainties’ complicate hypoglycemia findings comparing insulin degludec vs. glargine

September 20, 2019
Adults with insulin-dependent type 2 diabetes assigned to insulin degludec for up to 88 weeks experienced fewer severe or confirmed symptomatic…
Meeting News

SUSTAIN 10: Semaglutide tops liraglutide providing support for changing prescribing patterns

September 20, 2019
Among a cohort of adults with type 2 diabetes already using oral medications, those assigned to add a weekly injection of 1 mg semaglutide vs. 1.2 mg…

Meeting Calendar

European Association for the Study of Diabetes Annual Meeting

September 21, 2020 - September 25, 2020

  • Location: Vienna, Austria
  • Website